View Article

Abstract

Drug administration and delivery options have advanced greatly in the last 30 years and have become a significant area of drug development. Conventional drug delivery systems have some caveats. Monitoring drug plasma concentration is, for example, necessary when using a medication, especially in the case of drugs with a short half-life. Frequent application of the drug can pose compliance issues to patients and change drug plasma concentration. While new drugs can overcome some of these issues, specifically controlled delivery that can sustain drug plasma levels over a longer period of time by sustained release can be very valuable. Drug delivery is also a means to improve drug bioavailability, therefore, enhancing treatment and patient compliance. There are several types of delivery systems: liposomes, ethosomes, phytosomes, micro emulsions, and microspheres. Microspheres have unique benefits because they allow sustained release from polymer matrices that are biodegradable and have no side effects. This is an important consideration because microspheres are widely used in many medical disciplines, including oncology, radiology, gynecology, cardiology, pulmonology, diabetes and medicine. This review summarizes various types of microspheres and recent innovations in their formulation. Further, microspheres can be studied and functionalized, using multiple methods.

Keywords

medical disciplines, including oncology, radiology, gynecology, cardiology, pulmonology, diabetes and medicine

Introduction

Microspheres are defined as spherical systems consisting of therapeutic agents dispersed either in a molecular (non-granular) system or in large particles within a polymer matrix. They can also be described as structures containing at least one continuous phase of one or more miscible polymers in which evenly dispersed drug particles are present. They typically exist with sizes ranging from 1 to 1000 micro-meters and can be in microcrystalline form, or present some form of drug-dispersion systems in certain solvents or solutions. Examples of drugs within microspheres can be compounded surgical materials or ballistics.

Microspheres and microcapsules are often used interchangeably, yet they represent different structures. When discussing microspheres (micrometrics), they have drug molecules that are evenly dispersed. Microcapsules represent a clear core in a clearly defined polymer shell. Sometimes both are referred to as micro-particles.

Microspheres can be made from any natural or synthetic polymer such as biodegradable polymers, ceramics, glass, or synthetic plastics. Polyethylene and polystyrene are commonly used polymeric microspheres, with polystyrene being of particular interest to biomedical researchers because they have strong binding and anti-ligand capacity for proteins and thus are appropriate for applications like cell sorting, antibody precipitation, and assorted immunoassays.

The primary advantage of microspheres is their ability to control the release of drugs, increasing bioavailability and minimizing side effects. Because of their small size, they can be widely distributed throughout the gastrointestinal tract to improve drug absorption and decrease localized mucosal irritation. Microencapsulation techniques allow delivery properties to be specifically tailored for sustained, delayed, or target delivery, and are therefore extremely valuable in mitigating the limitations of conventional drug regimens.

Microspheres Advantages:

  1. Drugs with low solubility are more soluble when their particle size is reduced.
  2. The microsphere's therapeutic effect is prolonged and sustained.
  3. It maintains a consistent drug level in the blood, improving patient compliance.
  4. Reduced toxicity and dosage.
  5. They are excellent for drug distribution because they don't promote the enzymatic or photolytic breakdown of the drug.
  6. Reduced frequency of dosages enhances patient compliance.
  7. Improved use of medicine improves bioavailability and reduces side effects severity or frequency.
  8. It helps protect against drug irritant action on GIT.
  9. Compared to larger polymer implants, biodegradable microspheres do not require surgical insertion or removal because they are smaller.
  10. Drug delivery controls release Biodegradable microspheres are used to control the release of drugs, reducing both toxicity and recurrent injection problems.
  11. Odor and taste masking.
  12. Liquids and oils are solidified for ease of use.
  13. Protected from the environment (moisture, light, etc).
  14. Improved powder rheology.
  15. It facilitates dispersing water-insoluble compounds in aqueous media.

Limitations of Microspheres:

  1. The dosage form will not release as intended.
  2. The rate of release can be affected by dietary intake and the gut transit time. 
  3. The rate of release can vary from one dose to another.
  4. These dosage forms usually have higher drug load so damage to the release properties can increase possible toxicity.
  5. The dosage forms should not be crushed into particles or chewed.

Materials Utilized for Preparation of Microspheres:

Polymers are the main materials utilized in microsphere formulation. The polymers are generally classified into two categories:

  1. Natural Polymers:

Natural polymers are obtained from biological sources such as carbohydrates, chemically modified carbohydrates, and proteins. These materials are biocompatible, biodegradable, and frequently selected for drug delivery purposes due to their lower toxicity and ease of degradation.

  1. Carbohydrates - Examples include:
  • Starch
  • Agarose
  • Chitosan
  • Carrageenan
  1. Chemically Modified Carbohydrates:

These are altered to enhance their stability, solubility, and ability to carry drugs. Examples include:

  • Polysearch
  • Polydextran
  1. Proteins:

Proteins occurring naturally in microsphere formulations are:

  • Collagen
  • Albumin
  • Gelatine
  1. Synthetic Polymers:

Synthetic polymers provide more control of physicochemical properties like degradation rate, mechanical strength, and release kinetics. These are further categorized as:

  1. Biodegradable Polymers:

These naturally break down in the body to give non-toxic by-products. Some common examples are:

  • Polyanhydrides
  • Polylactides (PLA)
  • Polyglycolides (PGA)
  • Poly(lactic-co-glycolic acid) (PLGA)
  • Polyalkyl cyanoacrylates
  1. Non-Biodegradable Polymers:

These are employed in a situation where the drug release over an extended period or structural integrity is necessary. Some examples include:

  • Polymethylmethacrylate (PMMA)
  • Epoxy resins
  • Acrolein
  • Glycidyl methacrylate

Each of these polymer types possesses unique benefits based on the desired application, release profile, and delivery site. Choice of material is important to making the microsphere-based drug delivery system safe, effective, and functional.

Ideal Microsphere Properties:

In order to be used as successful drug delivery systems, microspheres need to have several ideal properties that would guarantee their therapeutic efficacy, as well as their stability and safety for the patients.

These include:

  • Controlled and Sustained Drug Release: It should be feasible for microspheres to release the drug that is encapsulated in them in a manner that is both predictable and sustained so as to achieve uniform therapeutic levels and minimize the dosing frequency.
  • Biocompatibility: The materials used for the production of microspheres should be absolutely safe for the human body and should not cause any kind of immune or inflammatory reaction due to which the product will be harmful to the patient.
  • Biodegradability: Microspheres should degrade into harmless by-products which are readily removed from the body, particularly for those systems to be used for long-term implantation or application.
  • High Drug Loading Capacity: High drug entrapment efficiency is crucial in order to reduce the quantity of carrier material needed and diminish the volume of the total dose.
  • Particle Size Uniformity: Even particle size distribution (generally within the 1–1000 µm range) provides consistent drug release, enhanced bioavailability, and enhanced targeting.
  • Stability: Microspheres must have no change in their physical, chemical, and functional integrity upon storage and over the course of the intended shelf life.
  • Surface Properties: The microsphere surface should be smooth and can be altered to improve targeting capacity, minimize aggregation, and optimize interaction with biological systems.
  • Reproducibility: The manufacturing process should repetitively produce microspheres with consistent properties from batch to batch.
  • Sterilizability: Microspheres must be sterilizable without damage to their structure or drug content, especially for parenteral or implantable purposes.
  • Ease of Administration: Microspheres must be easily administered via standard routes like oral, injectable, or inhalable form, depending on the use.

Types of Microspheres:

Microspheres are drug delivery systems with varied functionalities, compositions, or administration routes. The following are the broad types frequently researched and utilized in pharmaceutical and biomedical applications:

  1. Bio adhesive Microspheres:

Bio adhesive microspheres are made to stick to mucosal surfaces like the buccal, ocular, nasal, rectal, and vaginal membranes with the help of water-soluble polymers. The sticking of bio adhesive microspheres at the place of absorption increases the time of stay at the site of absorption, hence enhancing drug bioavailability and therapeutic action by intimate and continuous contact with the absorption surface.

Fig.1 - Bio adhesive Microspheres

Magnetic Microspheres:

Magnetic microspheres are injected into the body for targeted drug delivery along with external magnetic fields. The systems use magneto tactic materials (e.g., chitosan, dextran) to move the microspheres to the desired location and thus expose less drug to the body.

Therapeutic Application: Delivery of chemotherapeutic drugs, especially for liver tumors.

Diagnostic Application: Used in imaging (e.g., detection of liver metastases) with super paramagnetic iron oxide nanoparticles.

  1. Diagnostic Microspheres:

These microspheres are specially made for visualizing and diagnostic purposes. Besides being combined with or carrying drugs, contrast agents may also be injected into magnetic microspheres for local imaging of a given area due to the deposit of the target tissue under the influence of an external magnetic field.

  1. Floating Microspheres:

Floating or gastro-retentive microspheres have a lower density than the gastric fluids so they float and stay in the stomach for longer periods. This extends gastric residence time, improves drug absorption in the upper gastrointestinal tract, and ensures controlled drug release, lowering dosing frequency and plasma drug fluctuation.

Fig.2 - Floating Microspheres

Radioactive Microspheres:

Radioactive microspheres are administered mainly for radio embolization therapy to treat cancer, especially liver cancers. They are usually 10–30 µm in size (larger than capillaries) and are injected intra-arterially, where they selectively become lodged within the tumour vasculature. The microspheres give off localized radiation (α, β, or γ rays), which delivers high doses to tumour tissue without damaging healthy tissue.

  1. Mucoadhesive Microsphere:

Mucoadhesive microspheres are designed to stick to mucosal surfaces for the improvement of both localized and systemic drug release. Advantages are extended contact with the mucosa, greater drug absorption, improved bioavailability, and site-specific delivery. They can be administered through any of the mucosal routes such as ocular, nasal, gastrointestinal, and urinary tracts.

  1. Polymeric Microsphere:

Polymeric microspheres are categorized depending on the polymer used:

  1. Biodegradable Polymeric Microspheres:

Prepared from materials like PLGA, polylactic acid, and polyglycolic acid, these microspheres disintegrate into non-toxic products and are suited for controlled and sustained release.

2. Synthetic Non-Biodegradable Polymeric Microspheres:

Made of polymers including Polymethylmethacrylate (PMMA), these microspheres exhibit drug release over a long period and structural integrity where biodegradability is not needed.

Fig.3 - Biodegradable and Non-Biodegradable Polymeric Microspheres

Preparation Methods of Microspheres:

There are numerous ways to make microspheres depending on the size, shape, drug release profile, and polymer type. The main classes of methods for preparing microspheres are physical, chemical, and physicochemical ones.

  1. Single Emulsion Technique:

This method is largely used for the fabrication of microspheres from natural polymers such as proteins and carbohydrates. The polymer is dissolved in water and then, to disperse it, a non-aqueous medium (for instance, oil) is added. An emulsion of water-in-oil (w/o) is thus obtained. The crosslinking of the dispersed globules can be carried out by heat or by using chemical agents (e.g., glutaraldehyde, formaldehyde). Nevertheless, chemical cross-linking can make the drug contaminated with toxic reagents and affect drug stability and bioactivity.

Fig.4 - Single Emulsion Technique

Double Emulsion Technique (W/O/W):

The Double Emulsion (W/O/W) method is designed for the encapsulation of water-soluble drugs, proteins, peptides, and vaccines and is essentially the manufacture of a water-in-oil-in-water (W/O/W) emulsion. The drug in the internal aqueous phase is first combined with a polymer-dissolved organic phase and then, an external aqueous phase is added and mixed again. The method enables not only a high encapsulation efficiency but also the safety of the biomolecules that are fragile.

Fig.5 - Double Emulsion Technique (W/O/W)

Polymerization Techniques:

One of the methods to produce microspheres is through polymerization where the monomers are subjected to chemical reactions that lead to the formation of polymer chains, which, in turn, encapsulate the drug.

  1. Conventional Polymerization: It comprises the main processes of bulk, suspension, precipitation, emulsion, and micellar polymerization. The drug release can be either during or after polymerization. In suspension polymerization (sometimes called pearl polymerization), the monomers are suspended in a water medium.
  2.  Interfacial Polymerization: Describes the reaction between monomers at the interfaces of two immiscible liquids that results in the formation of a polymer membrane around the core material.
  1. Phase Separation (Coacervation) Technique:

The method exploits the separation of a polymer-rich phase (Coacervation) from a solution by adding a non-solvent or an incompatible polymer. The coacervation phase holds the drug and is attached to the microspheres to be fixed. Hydrophilic, hydrophobic, and lipophilic drugs can be encapsulated by this method, generally resulting in a high drug load.

Fig.6 - Phase Separation (Coacervation) Technique / Coacervation method

  1. Spray Drying Technique:

One of the most frequent methods in which a drug solution with a polymer is sprayed into a hot chamber for drying, whereby the solvent is rapidly evaporated, and dry microspheres are formed. Besides this, it allows the production of a large quantity, the control of the particle size (generally 1–100 µm) and the use of materials that are sensitive to heat because of a short time of exposure.

Fig.7 - Spray Drying Technique

6. Spray Congealing Technique:

Essentially the same process as spray drying, however the microcapsules are solidified by the cooling of the molten blend or by the spraying into a non-solvent. Hence the method is suitable for drugs in the lipophilic phase and for substances like waxes, fatty acids, and polymers with a melting point of about 25°C (77°F).

Fig.8 - Spray Congealing Technique

Emulsion Cross-Linking Technique:

The water-based polymer solutions (for instance, gelatine) are mixed with oil to make a w/o emulsion. After that, the cross-linking is activated by the use of a chemical such as glutaraldehyde. Generally, this technique is utilized in the manufacturing of gelatine-based microspheres and is suitable for hydrophilic drugs.

  1. Solvent Evaporation Technique:

The drug is either dissolved or dispersed in a polymer solution and then, emulsified in a non-mixed continuous phase (generally oil). As the solvent is evaporated, microspheres are formed. This process is widely used for PLGA-based formulations and allows the production of monodisperse particles with tailored release profiles.

  1. Ionic Gelation Technique:

This is a gentle, water-soluble method that is perfect for the encapsulation of biomolecules that are sensitive to the process. Alginate or chitosan type polymers are ionically cross linked by using divalent or trivalent cations (e.g., Ca²?, Al³?). The microspheres solidify when they come into contact with the ionic solution and are further stabilized. Besides being pH-sensitive, it also enables targeted delivery, mainly adapted to the intestinal environment.

Fig.9 - Ionic Gelation Technique

Evaluation of Microspheres:

Characterization and evaluation of the microspheres are of vital importance to ensure their efficiency, stability, and suitability for drug delivery. Generally, the following parameters are being evaluated:

  1. Particle Size and Morphology:

Procedure: Optical microscopy with a calibrated micrometre is the most widely used method to measure particle size.

Importance: The size of the particles affects the drug release, absorption, and distribution in the body.

  1. Determination of Density:

Procedure: A multi-volume pycnometer is the tool used for the determination of the true density. The method is based on helium gas expansion.

Importance: Necessary for the understanding of microsphere flow behavior and packing.

  1. Point of Zero Charge:

Method: The measurement of micro-electrophoresis at different pH (3–10) was carried out to find the isoelectric point.

Importance: Helps in predicting the microsphere status in different physiological environments.

  1. Flow Properties:

Method: Flow properties were determined by Carr's Compressibility Index, Hausner's Ratio, and Angle of Repose through tapped and bulk density measurements.

Significance: Describes powder flow ability, a necessity for capsule filling and handling.

  1. Angle of Contact:

Method: The measurement was done by using a droplet placed in contact with microspheres and then observing it under an inverted microscope at 200°C.

Significance: The angle of contact identifies the material's nature, whether it is hydrophilic or hydrophobic, which in turn influences the wettability and the drug release.

  1. Percentage Yield:

Method: Percentage Yield = (Total weight of microspheres recovered x 100) / Total weight of polymer + drug

Significance: The Primary Indicator of the Efficiency of the Preparation Process.

  1. Swelling Index:

Method: Swelling Index=(((Mass of swollen microspheres – Mass of dried microspheres) / Mass of dry microspheres) x 100

Significance: The change in volume as a result of water uptake is the swelling index and it indicates the drug release behaviour that is still to come.

  1. Drug Content:

Method: 1 mL of filtrate is diluted with 0.1N NaOH and analysed with UV-Vis spectrophotometry.

Significance: This is the measurement of the actual drug concentration in the unit weight of microspheres.

  1. Entrapment Efficiency:

Method: The crushed microspheres were sonicated and then filtered. Drug content was determined using UV-Vis spectrophotometry.

Significance: The extent to which the drug has been successfully encapsulated is indicated by the entrapment efficiency and thus, it is the factor that determines the therapeutic efficacy.

  1. Scanning Electron Microscopy (SEM):

Method: Microspheres coated with a conductive metal (e.g., platinum) are exposed to an electron beam for imaging.

Significance: Provides surface feature visualization and structural integrity confirmation.

  1. Fourier Transform Infrared Spectroscopy (FTIR):

Method: ATR-FTIR checks for retention of functional groups and any changes due to drug-polymer interaction.

Significance: Identifies chemical compatibility and any structural changes in the formulation.

  1. Thermal Analysis:

Method: Various thermal properties are identified by methods like DSC (Differential Scanning Calorimetric) and TGA (Thermo gravimetric Analysis).

Significance: Confirms thermal stability, drug-polymer interactions and pattern of degradation.

  1. In Vitro Drug Release Studies:

Method: Performed on a USP/BP dissolution apparatus (paddle or basket method) with media volumes of 100–500 mL, at 50–100 rpm.

Significance: Provides release profiles to predict in vivo performance and dosage frequency.

Applications of Microspheres:

Microspheres are biocompatible carriers that have merged in different directions to deliver a drug successfully. Their ability to release drugs in a controlled manner and target specific tissues is the reason for their widespread use in medicine, biotechnology, and diagnostic fields, parts of which are given below:

  1. Ophthalmic Drug Delivery:

Bio adhesion, permeability increase, and favorable physicochemical properties are the name of the features with which polymeric microspheres can be successful in a long-lasting ocular drug delivery system.

  1. Oral Drug Delivery:

For their pH-sensitive polymer microspheres are made that are primarily used in oral formulations to grant controlled release along with a better compliance of the patients, which is a feature of their film-forming ability that makes them the first choice over traditional tablets.

  1. Nasal Drug Delivery:

Bio adhesive polymers (e.g., starch, dextran, albumin, chitosan, gelatine) microspheres are prepared in such a manner that they can be wetted and can also be well sticking to the nasal mucosa, thus, they allow for being the drug repositories of increased residence time and bioavailability for systemic or CNS administration.

  1. Gene Delivery:

Microspheres backed by Mucoadhesive and transport-promoting attributes can really be oral carriers for gene therapy, using materials such as chitosan, gelatine, viral vectors, cationic liposomes, and polycation complexes.

  1. Local and Intratumoral Drug Delivery:

Microspheres (PLGA, chitosan, PCL) are the carriers for chemotherapeutic agents like paclitaxel to be targeted locally at the tumor site, thus the drug is delivered in a targeted and time-release manner with minimal systemic toxicity.

  1. Gastrointestinal Drug Delivery:

Floating microspheres prepared from Eudragit, ethyl cellulose, Carbopol, BSA, or gelatine not only provide prolonged gastric residence but also enable site-specific, controlled drug release in the GI tract.

  1. Transdermal Drug Delivery:

Microspheres help transdermal systems to be more effective which are film-forming polymers like chitosan and alginate. Drug diffusion rate is controlled by cross-linking and membrane thickness.

  1. Colonic Drug Delivery:

Microspheres are the carriers for drugs in the colon, for example, insulin is delivered with the help of polymers such as chitosan and thus, these drugs are useful for diseases like IBD or colorectal cancer.

  1. Vaginal Drug Delivery:

Thiolated chitosan is the main material for making microspheres intended for local treatment of genitourinary tract mycotic infections. Besides chitosan, the most common materials in the synthesis of microspheres are gelatin and polylactic-co-glycolic acid (PLGA).

  1. Targeted Delivery through Micro particulate Carriers:

Micro particulate drug delivery systems fabricated by an extrusion–spheronization technique are a means of drug targeting to the specific sites of the body. Such systems can be made from materials, e.g., chitosan and microcrystalline cellulose.

  1. Extended Biomedical Applications:
  • Prolonged release of peptides, proteins, hormones, and insulin.
  • Gene therapy with plasmid DNA.
  • Vaccine delivery for illnesses such as hepatitis, pertussis, and influenza.
  • Cancer targeting by either passive or active ways (e.g., Doxorubicin, Leishmaniasis).

Magnetic microspheres for:

  • Seizing stem cells.
  • Removing bone marrow.
  • Capturing antibody and toxin via affinity chromatography.
  • Isolation of cells and diagnostics.
  • Diagnostic usage for detection of bacterial, viral, and fungal infections.

CONCLUSION:

The review showcases the effectiveness and utility of microspheres as advanced systems for drug delivery. Microspheres can be manufactured via multiple preparation methods for broad pharmaceutical applications that provide controlled, targeted, and sustained delivery of therapeutic medications. Microspheres have applications that meet the needs for diverse routes of administration, including oral and topical drug delivery; targeted therapy; and biotechnological applications in gene therapy.

Emerging technology for both defined therapies and industry utilization based on microspheres present concrete clinical and commercial benefits that will enhance safety, lower toxicity, and optimize drug administration and effective therapy. As more companies implement these technologies, it is clear that microsphere-based systems have specific advantages over traditional delivery systems.

Additionally, their uses do not involve only drug delivery; microspheres can also be utilized in cancer treatment therapies, bimolecular diagnostics, and imaging of tumours which reinforce the role of microspheres in the future of healthcare. Aspects of microspheres such as targeting specificity, subject compliance, and multiple functional applications are making microspheres a primary platform in the advancement of medication delivery and biomedical science.

REFERENCE

  1. Reddy BV, Krishnaveni K. Formulation and evaluation of efavirenz microspheres. Der Pharmacia letters. 2015; 7(6):1-9.
  2. Thanoo BC, Sunny MC, Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. Journal of pharmacy and pharmacology. 1992 Apr; 44(4):283-6.
  3. Sahil K, Akanksha M, Premjeet S, Bilandi A, Kapoor B. Microsphere: A review. Int. J. Res. Pharm. Chem. 2011;1(4):1184 98.
  4. Virmani T, Gupta J. Pharmaceutical application of microspheres: an approach for the treatment of various diseases. Int J Pharm Sci Res. 2017; 8(8):3253-60.
  5.  Li SP, Kowarski CR, Feld KM, Grim WM. Recent advances in microencapsulation technology and equipment. Drug Development and Industrial Pharmacy. 1988 Jan 1; 14(2-3):353-76.
  6. Thakur D, M.pharm, presentation on introduction, advantage, disadvantage, and ideal properties of microsphere, slideshare. Published on Oct 17, 2016.
  7. Kunchu, K., VeeraAshwani, R., et al., 2010. Albumin microspheres: A unique system as drug delivery carriers for non-steroidal anti inflammatory drugs. Journal of Drug Delivery and Therapeutics, 5(2), pp.12.
  8. Vyas S.P. and Khar R.K, Targeted and Controlled drug delivery: 07 Edition, 418.
  9. Ramteke K.H, Jadhav V.B, Dhole S.N: Microspheres: as carriers used for novel drug delivery system IOSR Journal of Pharmacy: 2012:2(4):44-48. https://doi.org/10.9790/3013-24204448
  10. Giri Prasad B. S, Gupta V. R., Devanna N, Jayasurya K: Microspheres As Drug Delivery System - A Review Journal of Global Trends in Pharmaceutical Sciences.
  11. Kadam, N.R. and Suvarna, V., 2015. Microsphere: a brief review. Asian Journal of Biomedical and Pharmaceutical Sciences, 5(47), pp.13-19.
  12. Saqib, M., Nazmus, B.K., Liu, F. and Zhong, F., 2022. Hydrogel microspheres for designing future foods: Structures, mechanisms, applications, and challenges. Food Hydrocolloids for Health, 2, 100073.
  13. Alagusundaram, M., Madhu, C., Umashankari, K., Attuluri, B., Lavanya, C. and Ramakant, S., 2009. Microspheres: As novel drug delivery system. International Journal of ChemTech Research, 1(3), pp.526-534.
  14. Suvarna, V., 2015. Microspheres: a brief review. Asian Journal of Biomedical and Pharmaceutical Sciences, 5(47), pp.13-19.
  15. Prasanth, V.V., Moy, A.C., Mathew, S.T. and Mathapan, R., 2011. Microspheres: An overview. International Journal of Research in Pharmaceutical and Biomedical Sciences, 2, pp.3328-3334.
  16.  https://www.researchgate.net/figure/Schematic-representation of-the-solvent-evaporation-process-for-the-manufacture of_fig1_343325985
  17. http://www.gate2tech.com/IMG/jpg/single_em ulsion.jpg
  18. http://www.gate2tech.com/IMG/jpg/double_e mulsion.jpg.
  19. Alagusundaram M, Chetty MSC, Umashankari K, Badarinatrh A V, Lavanya C, Ramakant S, "Microspheres as a Novel Drug Delivery System-A Review,," International Journal of Chemical Technological Research., vol. 1,2009; pp. 526-534.
  20. Kadam N.R, "Microspheres: A Brief Review,," Asian Journal of Biomedical and Pharmaceutical Sciences., vol. 5, no. (47),2015; pp. 13-19.
  21. Gauravkumar R. Agarwal, "Formulation, Physicochemical Characterization and invitro Evaluation of Human Insulin-loaded microspheres as Potential Oral Carrier,,"ProgBiomater., vol. 6,2017; pp. 125-136.
  22. Gurung and Kakar, "An Overview on Microspheres,," International Journal of Health and Clinical Research., vol. 3, no. (1), 2020;pp. 11-24. 
  23. Chitra Singh, Suresh Purohit, Madhu Singh, B.L. Pandey,"Design and Evaluation of Microspheres: A Review,," Journal of Drug Delivery Research., vol. 2, no. (2),2013 pp. 1074-2319.
  24. NavidJubaerAyon, "Preparation and Characterization of Gliclazide Incorporated Cellulosic Microspheres,," Journal of Pharmaceutical Sciences., vol. 13, no. (2),2014; pp. 149-166.
  25. Gogu P.K, " Preparation and invivo Characterization of Spray dreid Microspheres," Indian Journal of Pharmaceutical Sciences.,2010; pp. 346-352.
  26. Abhay M.L, "Formulation and Characterization of Microspheres,," Journal of Pharmaceutical Drug Delivery Technologies., vol. 1, no. (2), 2015;pp. 65-69.
  27. Venkatesh D.P, "Formulation and Evaluation of Microspheres Containing Fluvastatin Sodium,," International Journal of Drug Development and Research,, vol. 4, no. (2),2012;pp. 306-314.
  28. Chowdary K. P.R, Suri B.J, "Permeability of Ethylene Vinyl Accetate Copolymer Microcapsules,," Indian Journal Pharmaceutical Sciences., no. (1),2003; pp. 62-65.
  29. Rakesh Gupta, "Charcterization of Captopril-Ethyl Cellulose Microspheres by Thermal Analysis,," Journal of Drug Development and Research ,, vol. 2, no. (2),2010; pp. 394-398.
  30. Verma NK, Alam G, Vishwakarma DK, Mishra JN, Khan WU, Singh AP et al. Recent Advances in microspheres technology for drug delivery. Int https://doi.org/10.37285/ijpsn.2015.8.2.2 J PharmSciNanotechnol. 2015 Apr;8(2):2799-813.

Reference

  1. Reddy BV, Krishnaveni K. Formulation and evaluation of efavirenz microspheres. Der Pharmacia letters. 2015; 7(6):1-9.
  2. Thanoo BC, Sunny MC, Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. Journal of pharmacy and pharmacology. 1992 Apr; 44(4):283-6.
  3. Sahil K, Akanksha M, Premjeet S, Bilandi A, Kapoor B. Microsphere: A review. Int. J. Res. Pharm. Chem. 2011;1(4):1184 98.
  4. Virmani T, Gupta J. Pharmaceutical application of microspheres: an approach for the treatment of various diseases. Int J Pharm Sci Res. 2017; 8(8):3253-60.
  5.  Li SP, Kowarski CR, Feld KM, Grim WM. Recent advances in microencapsulation technology and equipment. Drug Development and Industrial Pharmacy. 1988 Jan 1; 14(2-3):353-76.
  6. Thakur D, M.pharm, presentation on introduction, advantage, disadvantage, and ideal properties of microsphere, slideshare. Published on Oct 17, 2016.
  7. Kunchu, K., VeeraAshwani, R., et al., 2010. Albumin microspheres: A unique system as drug delivery carriers for non-steroidal anti inflammatory drugs. Journal of Drug Delivery and Therapeutics, 5(2), pp.12.
  8. Vyas S.P. and Khar R.K, Targeted and Controlled drug delivery: 07 Edition, 418.
  9. Ramteke K.H, Jadhav V.B, Dhole S.N: Microspheres: as carriers used for novel drug delivery system IOSR Journal of Pharmacy: 2012:2(4):44-48. https://doi.org/10.9790/3013-24204448
  10. Giri Prasad B. S, Gupta V. R., Devanna N, Jayasurya K: Microspheres As Drug Delivery System - A Review Journal of Global Trends in Pharmaceutical Sciences.
  11. Kadam, N.R. and Suvarna, V., 2015. Microsphere: a brief review. Asian Journal of Biomedical and Pharmaceutical Sciences, 5(47), pp.13-19.
  12. Saqib, M., Nazmus, B.K., Liu, F. and Zhong, F., 2022. Hydrogel microspheres for designing future foods: Structures, mechanisms, applications, and challenges. Food Hydrocolloids for Health, 2, 100073.
  13. Alagusundaram, M., Madhu, C., Umashankari, K., Attuluri, B., Lavanya, C. and Ramakant, S., 2009. Microspheres: As novel drug delivery system. International Journal of ChemTech Research, 1(3), pp.526-534.
  14. Suvarna, V., 2015. Microspheres: a brief review. Asian Journal of Biomedical and Pharmaceutical Sciences, 5(47), pp.13-19.
  15. Prasanth, V.V., Moy, A.C., Mathew, S.T. and Mathapan, R., 2011. Microspheres: An overview. International Journal of Research in Pharmaceutical and Biomedical Sciences, 2, pp.3328-3334.
  16.  https://www.researchgate.net/figure/Schematic-representation of-the-solvent-evaporation-process-for-the-manufacture of_fig1_343325985
  17. http://www.gate2tech.com/IMG/jpg/single_em ulsion.jpg
  18. http://www.gate2tech.com/IMG/jpg/double_e mulsion.jpg.
  19. Alagusundaram M, Chetty MSC, Umashankari K, Badarinatrh A V, Lavanya C, Ramakant S, "Microspheres as a Novel Drug Delivery System-A Review,," International Journal of Chemical Technological Research., vol. 1,2009; pp. 526-534.
  20. Kadam N.R, "Microspheres: A Brief Review,," Asian Journal of Biomedical and Pharmaceutical Sciences., vol. 5, no. (47),2015; pp. 13-19.
  21. Gauravkumar R. Agarwal, "Formulation, Physicochemical Characterization and invitro Evaluation of Human Insulin-loaded microspheres as Potential Oral Carrier,,"ProgBiomater., vol. 6,2017; pp. 125-136.
  22. Gurung and Kakar, "An Overview on Microspheres,," International Journal of Health and Clinical Research., vol. 3, no. (1), 2020;pp. 11-24. 
  23. Chitra Singh, Suresh Purohit, Madhu Singh, B.L. Pandey,"Design and Evaluation of Microspheres: A Review,," Journal of Drug Delivery Research., vol. 2, no. (2),2013 pp. 1074-2319.
  24. NavidJubaerAyon, "Preparation and Characterization of Gliclazide Incorporated Cellulosic Microspheres,," Journal of Pharmaceutical Sciences., vol. 13, no. (2),2014; pp. 149-166.
  25. Gogu P.K, " Preparation and invivo Characterization of Spray dreid Microspheres," Indian Journal of Pharmaceutical Sciences.,2010; pp. 346-352.
  26. Abhay M.L, "Formulation and Characterization of Microspheres,," Journal of Pharmaceutical Drug Delivery Technologies., vol. 1, no. (2), 2015;pp. 65-69.
  27. Venkatesh D.P, "Formulation and Evaluation of Microspheres Containing Fluvastatin Sodium,," International Journal of Drug Development and Research,, vol. 4, no. (2),2012;pp. 306-314.
  28. Chowdary K. P.R, Suri B.J, "Permeability of Ethylene Vinyl Accetate Copolymer Microcapsules,," Indian Journal Pharmaceutical Sciences., no. (1),2003; pp. 62-65.
  29. Rakesh Gupta, "Charcterization of Captopril-Ethyl Cellulose Microspheres by Thermal Analysis,," Journal of Drug Development and Research ,, vol. 2, no. (2),2010; pp. 394-398.
  30. Verma NK, Alam G, Vishwakarma DK, Mishra JN, Khan WU, Singh AP et al. Recent Advances in microspheres technology for drug delivery. Int https://doi.org/10.37285/ijpsn.2015.8.2.2 J PharmSciNanotechnol. 2015 Apr;8(2):2799-813.

Photo
Raskar Tanvi
Corresponding author

Genba Sopanrao Moze College of Pharmacy.

Photo
Pawar Pratiksha
Co-author

Genba Sopanrao Moze College of Pharmacy.

Photo
Priya Daingade
Co-author

Genba Sopanrao Moze College of Pharmacy.

Photo
Tushar T. Shelke
Co-author

Genba Sopanrao Moze College of Pharmacy.

Raskar Tanvi*, Pawar Pratiksha, Priya Daingade, Tushar T. Shelke, A Review of Microspheres: Types, Formulation Techniques, Characterization and Application, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 10, 350-366 https://doi.org/10.5281/zenodo.17264164

More related articles
A Comprehensive Review on Dry Eye Syndrome...
Gajanan Sormare , Suraj Nirwan, Deep Selokar, Vrushabh Hete, Nish...
Review Article on Novel Drug Delivery System ...
Dr. C. S. Parameswari, K.Mounika, B Manasa, N.Navya sree , M.Srey...
Stem Cell-Based Therapeutic Strategies in Diabetes Mellitus...
Dharati More, Samiksha Ghatage, Snehal Magdum, Rutika Chougule, ...
Formulation And Evaluation Of Colon Target Matrix Tablet Of Mesalamine Using Syn...
Ritesh Rana, Akshit Sharma, Parshuram Rai, Priyanka Devi, ...
Related Articles
Modulating The Solubility of Mesalamine by Means of Cocrystals...
Bhakti Pawar, Dr. Afaque Raza Mehoboob Ansari, ...
Formulation and Evaluation of Polyherbal Energy Drink...
Chetan Thombre, Prachi Murkute, Ashwini Pundkar, Dr. Santosh Payghan, Vishal Waghmode, ...
A Comprehensive Review on Dry Eye Syndrome...
Gajanan Sormare , Suraj Nirwan, Deep Selokar, Vrushabh Hete, Nishanth Awandekar, Milind Umekar, ...
More related articles
A Comprehensive Review on Dry Eye Syndrome...
Gajanan Sormare , Suraj Nirwan, Deep Selokar, Vrushabh Hete, Nishanth Awandekar, Milind Umekar, ...
Review Article on Novel Drug Delivery System ...
Dr. C. S. Parameswari, K.Mounika, B Manasa, N.Navya sree , M.Sreya, M.Rajeswari, E. Anusha, ...
A Comprehensive Review on Dry Eye Syndrome...
Gajanan Sormare , Suraj Nirwan, Deep Selokar, Vrushabh Hete, Nishanth Awandekar, Milind Umekar, ...
Review Article on Novel Drug Delivery System ...
Dr. C. S. Parameswari, K.Mounika, B Manasa, N.Navya sree , M.Sreya, M.Rajeswari, E. Anusha, ...